chr10-90912651-GTAAA-G
Variant summary
Our verdict is Benign. The variant received -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_014391.3(ANKRD1):c.*211_*214delTTTA variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00569 in 499,142 control chromosomes in the GnomAD database, including 70 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.015 ( 54 hom., cov: 31)
Exomes 𝑓: 0.0018 ( 16 hom. )
Consequence
ANKRD1
NM_014391.3 3_prime_UTR
NM_014391.3 3_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 2.82
Genes affected
ANKRD1 (HGNC:15819): (ankyrin repeat domain 1) The protein encoded by this gene is localized to the nucleus of endothelial cells and is induced by IL-1 and TNF-alpha stimulation. Studies in rat cardiomyocytes suggest that this gene functions as a transcription factor. Interactions between this protein and the sarcomeric proteins myopalladin and titin suggest that it may also be involved in the myofibrillar stretch-sensor system. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -10 ACMG points.
BP6
Variant 10-90912651-GTAAA-G is Benign according to our data. Variant chr10-90912651-GTAAA-G is described in ClinVar as [Likely_benign]. Clinvar id is 301602.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.0145 (2208/152270) while in subpopulation AFR AF = 0.0506 (2103/41540). AF 95% confidence interval is 0.0488. There are 54 homozygotes in GnomAd4. There are 1023 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position FAILED quality control check.
BS2
High Homozygotes in GnomAd4 at 54 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD1 | NM_014391.3 | c.*211_*214delTTTA | 3_prime_UTR_variant | Exon 9 of 9 | ENST00000371697.4 | NP_055206.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0145 AC: 2200AN: 152152Hom.: 53 Cov.: 31 show subpopulations
GnomAD3 genomes
AF:
AC:
2200
AN:
152152
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00182 AC: 630AN: 346872Hom.: 16 AF XY: 0.00156 AC XY: 292AN XY: 186900 show subpopulations
GnomAD4 exome
AF:
AC:
630
AN:
346872
Hom.:
AF XY:
AC XY:
292
AN XY:
186900
Gnomad4 AFR exome
AF:
AC:
501
AN:
9862
Gnomad4 AMR exome
AF:
AC:
41
AN:
16370
Gnomad4 ASJ exome
AF:
AC:
0
AN:
10288
Gnomad4 EAS exome
AF:
AC:
1
AN:
21044
Gnomad4 SAS exome
AF:
AC:
4
AN:
43860
Gnomad4 FIN exome
AF:
AC:
7
AN:
18018
Gnomad4 NFE exome
AF:
AC:
21
AN:
206824
Gnomad4 Remaining exome
AF:
AC:
55
AN:
19168
Heterozygous variant carriers
0
32
63
95
126
158
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0145 AC: 2208AN: 152270Hom.: 54 Cov.: 31 AF XY: 0.0137 AC XY: 1023AN XY: 74452 show subpopulations
GnomAD4 genome
AF:
AC:
2208
AN:
152270
Hom.:
Cov.:
31
AF XY:
AC XY:
1023
AN XY:
74452
Gnomad4 AFR
AF:
AC:
0.0506259
AN:
0.0506259
Gnomad4 AMR
AF:
AC:
0.00536368
AN:
0.00536368
Gnomad4 ASJ
AF:
AC:
0
AN:
0
Gnomad4 EAS
AF:
AC:
0
AN:
0
Gnomad4 SAS
AF:
AC:
0
AN:
0
Gnomad4 FIN
AF:
AC:
0.0000943396
AN:
0.0000943396
Gnomad4 NFE
AF:
AC:
0.000117585
AN:
0.000117585
Gnomad4 OTH
AF:
AC:
0.00661626
AN:
0.00661626
Heterozygous variant carriers
0
109
218
326
435
544
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
28
56
84
112
140
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
9
AN:
3476
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Dilated Cardiomyopathy, Dominant Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Mutation Taster
=100/0
polymorphism
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at